{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T04:52:15Z","timestamp":1781844735726,"version":"3.54.5"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ijbiomac.2025.149046","type":"journal-article","created":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T16:18:06Z","timestamp":1764001086000},"page":"149046","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P1","title":["Integrin \u03b28: A novel prognostic biomarker for ovarian cancer identified through multi-omics-based prognostic models and experimental validation"],"prefix":"10.1016","volume":"335","author":[{"given":"Jinhan","family":"Yao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weina","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junrong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengru","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuquan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ijbiomac.2025.149046_bb0005","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/s41571-024-00881-3","article-title":"Global epidemiology of epithelial ovarian cancer","volume":"21","author":"Webb","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.149046_bb0010","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13148-018-0602-0","article-title":"Epigenetic therapy for ovarian cancer: promise and progress","volume":"11","author":"Moufarrij","year":"2019","journal-title":"Clin. Epigenetics"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.149046_bb0015","first-page":"17","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J. Clin."},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.149046_bb0020","doi-asserted-by":"crossref","first-page":"972","DOI":"10.6004\/jnccn.2022.0047","article-title":"NCCN Guidelines\u00ae Insights: Ovarian Cancer, Version 3.2022","volume":"20","author":"Armstrong","year":"2022","journal-title":"J. Natl. Compr. Canc. Netw."},{"issue":"12","key":"10.1016\/j.ijbiomac.2025.149046_bb0025","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22126532","article-title":"Ovarian cancer immunotherapy and personalized medicine","volume":"22","author":"Morand","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.149046_bb0030","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1200\/JCO.23.01771","article-title":"Treatment approaches for platinum-resistant ovarian cancer","volume":"42","author":"St Laurent","year":"2024","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.149046_bb0035","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1021\/acs.molpharmaceut.3c00986","article-title":"Immunotherapy for ovarian cancer: disappointing or promising?","volume":"21","author":"Deng","year":"2024","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ijbiomac.2025.149046_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104001","article-title":"Multi-omics approaches for biomarker discovery in early ovarian cancer diagnosis","volume":"79","author":"Xiao","year":"2022","journal-title":"EBioMedicine"},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.149046_bb0045","doi-asserted-by":"crossref","first-page":"648","DOI":"10.3390\/cells10030648","article-title":"Prognostic cancer gene expression signatures: current status and challenges","volume":"10","author":"Qian","year":"2021","journal-title":"Cells"},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.149046_bb0050","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/s41568-018-0038-z","article-title":"Every step of the way: integrins in cancer progression and metastasis","volume":"18","author":"Hamidi","year":"2018","journal-title":"Nat. Rev. Cancer"},{"issue":"16","key":"10.1016\/j.ijbiomac.2025.149046_bb0055","doi-asserted-by":"crossref","DOI":"10.3390\/cells11162521","article-title":"Cell cycle regulation by integrin-mediated adhesion","volume":"11","author":"Kamranvar","year":"2022","journal-title":"Cells"},{"issue":"13","key":"10.1016\/j.ijbiomac.2025.149046_bb0060","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15133466","article-title":"Regulation and functions of \u03b16-integrin (CD49f) in cancer biology","volume":"15","author":"Khademi","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.149046_bb0065","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1091\/mbc.e12-07-0521","article-title":"\u03b1v\u03b28 integrin interacts with rhogdi1 to regulate rac1 and cdc42 activation and drive glioblastoma cell invasion","volume":"24","author":"Reyes","year":"2013","journal-title":"Mol. Biol. Cell"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.149046_bb0070","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3892\/or.2016.5276","article-title":"CoL11A1 is overexpressed in gastric cancer tissues and regulates proliferation, migration and invasion of HGC-27 gastric cancer cells in vitro","volume":"37","author":"Li","year":"2017","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.ijbiomac.2025.149046_bb0075","doi-asserted-by":"crossref","first-page":"8933","DOI":"10.12659\/MSM.911518","article-title":"Integrin subunit beta 8 (ITGB8) upregulation is an independent predictor of unfavorable survival of high-grade serous ovarian carcinoma patients","volume":"24","author":"He","year":"2018","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.ijbiomac.2025.149046_bb0080","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1186\/1471-2105-9-559","article-title":"WGNCA: an R package for weighted correlation network analysis","volume":"9","author":"Langfelder","year":"2008","journal-title":"BMC Bioinformatics"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.149046_bb0085","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"Pt 3","key":"10.1016\/j.ijbiomac.2025.149046_bb0090","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.semcancer.2022.03.027","article-title":"Molecular, cellular and systemic aspects of epithelial ovarian cancer and its tumor microenvironment","volume":"86","author":"Schoutrop","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.ijbiomac.2025.149046_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.artmed.2021.102164","article-title":"Artificial intelligence in gynecologic cancers: current status and future challenges - a systematic review","volume":"120","author":"Akazawa","year":"2021","journal-title":"Artif. Intell. Med."},{"issue":"20","key":"10.1016\/j.ijbiomac.2025.149046_bb0100","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1097\/CM9.0000000000002426","article-title":"Metabolic reprogramming in the immunosuppression of tumor-associated macrophages","volume":"135","author":"Wang","year":"2022","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.ijbiomac.2025.149046_bb0105","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ctrv.2019.04.005","article-title":"Hedgehog signaling inhibitors in solid and hematological cancers","volume":"76","author":"Cortes","year":"2019","journal-title":"Cancer Treat. Rev."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.149046_bb0110","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.ymthe.2020.11.026","article-title":"Targeted in vivo delivery of NF-\u03baB decoy inhibitor augments sensitivity of B cell lymphoma to therapy","volume":"29","author":"Zhang","year":"2021","journal-title":"Mol. Ther."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.149046_bb0115","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/s43018-023-00712-x","article-title":"The efficacy of chemotherapy is limited by intratumoral senescent cells expressing PD-L2","volume":"5","author":"Chaib","year":"2024","journal-title":"Nat. Cancer"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.149046_bb0120","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s12943-024-01967-3","article-title":"Drug resistance in ovarian cancer: from mechanism to clinical trial","volume":"23","author":"Wang","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ijbiomac.2025.149046_bb0125","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1186\/s12935-020-01344-2","article-title":"The prognostic value of ITGA and ITGB superfamily members in patients with high grade serous ovarian cancer","volume":"20","author":"Zhu","year":"2020","journal-title":"Cancer Cell Int."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.149046_bb0130","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/s41419-022-04959-7","article-title":"Paradoxical role of \u03b28 integrin on angiogenesis and vasculogenic mimicry in glioblastoma","volume":"13","author":"Liu","year":"2022","journal-title":"Cell Death Dis."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.149046_bb0135","doi-asserted-by":"crossref","DOI":"10.1242\/dev.200472","article-title":"The \u03b28 integrin cytoplasmic domain activates extracellular matrix adhesion to promote brain neurovascular development","volume":"149","author":"De","year":"2022","journal-title":"Development"},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.149046_bb0140","first-page":"1649","article-title":"miR-199a-3p enhances cisplatin sensitivity of ovarian cancer cells by targeting ITGB8","volume":"39","author":"Cui","year":"2018","journal-title":"Oncol. Rep."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025096035?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025096035?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T04:13:18Z","timestamp":1781842398000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813025096035"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":28,"alternative-id":["S0141813025096035"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.149046","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Integrin \u03b28: A novel prognostic biomarker for ovarian cancer identified through multi-omics-based prognostic models and experimental validation","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.149046","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"149046"}}